Clinical trial
Effect of Perioperative Use of Dexmedetomidine-esketamine Combination on Incidence of Moderate-to-severe Pain After Spinal Surgery: a Randomized Controlled Trial
NCT07523321 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Perioperative Use of Dexmedetomidine-esketamine Combination on Incidence of Moderate-to-severe Pain After Spinal Surgery: a Randomized Controlled Trial
- Lead sponsor
- Peking University First Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- April 30, 2026
- Completion date
- May 31, 2027
- Enrollment
- 274 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dexmedetomidine, esketamine, pain intensity, postoperative analgesia, spinal surgery